JPWO2024101159A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2024101159A5
JPWO2024101159A5 JP2024557309A JP2024557309A JPWO2024101159A5 JP WO2024101159 A5 JPWO2024101159 A5 JP WO2024101159A5 JP 2024557309 A JP2024557309 A JP 2024557309A JP 2024557309 A JP2024557309 A JP 2024557309A JP WO2024101159 A5 JPWO2024101159 A5 JP WO2024101159A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
group
disease
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557309A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024101159A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/038555 external-priority patent/WO2024101159A1/ja
Publication of JPWO2024101159A1 publication Critical patent/JPWO2024101159A1/ja
Publication of JPWO2024101159A5 publication Critical patent/JPWO2024101159A5/ja
Pending legal-status Critical Current

Links

JP2024557309A 2022-11-08 2023-10-25 Pending JPWO2024101159A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263423608P 2022-11-08 2022-11-08
PCT/JP2023/038555 WO2024101159A1 (ja) 2022-11-08 2023-10-25 医薬組成物、吸着方法、治療方法および予防方法

Publications (2)

Publication Number Publication Date
JPWO2024101159A1 JPWO2024101159A1 (https=) 2024-05-16
JPWO2024101159A5 true JPWO2024101159A5 (https=) 2025-07-08

Family

ID=91032613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557309A Pending JPWO2024101159A1 (https=) 2022-11-08 2023-10-25

Country Status (3)

Country Link
US (1) US20250262240A1 (https=)
JP (1) JPWO2024101159A1 (https=)
WO (1) WO2024101159A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4491187A4 (en) * 2022-04-21 2026-03-18 Murata Manufacturing Co Pharmaceutical composition, adsorption method, treatment method, and prevention method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008005055A2 (en) * 2005-12-29 2008-01-10 The Board Of Trustees Of The University Of Illinois Nanoparticles containing titanium oxide
CN109133162A (zh) * 2018-07-30 2019-01-04 大连理工大学 一种大比表面超薄二维氧化钛纳米片材料及制备方法
CN114917247B (zh) * 2022-05-18 2024-01-26 广东省疾病预防控制中心 纳米二氧化钛在防治肾损伤中的应用

Similar Documents

Publication Publication Date Title
Mousa et al. Clay nanoparticles for regenerative medicine and biomaterial design: A review of clay bioactivity
Ahmad et al. A critical review on the synthesis of natural sodium alginate based composite materials: An innovative biological polymer for biomedical delivery applications
JPWO2024101159A5 (https=)
CN108721690B (zh) 一种药物缓释型抗菌敷料的制备方法及其产品
JP2021536511A5 (https=)
JP7061811B2 (ja) 鉄含有酸化物／ナノカオリン複合止血剤及びその製造方法
Ban et al. Potential biomedical limitations of graphene nanomaterials
JP2004535384A5 (https=)
CN102892422B (zh) 用于抗炎治疗的含硅的可生物降解的材料
JP2014005302A5 (https=)
WO2010018855A1 (ja) 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
JP2008509928A5 (https=)
JP2004520473A5 (https=)
JP2012107063A5 (https=)
JP2008539267A5 (https=)
JP2022009021A5 (https=)
CN106633106A (zh) 一种含海藻酸钠的凹凸棒土/聚丙烯酸纳米复合凝胶及其制备方法
CN1091635A (zh) 作为具有抗郁作用药物的2-氨基-6-正丙基-氨基-4，5，6，7-四氢苯并噻唑应用
JPWO2023204278A5 (https=)
JP2007512377A5 (https=)
CN114767923A (zh) 一种复合水凝胶载银长效抗菌敷料及其制备方法和应用
JPS63502663A (ja) 獣医用治療組成物
EP3939984B1 (en) Crystal form a of 2'-fluoro-4'-substituted nucleoside analog i and preparation method therefor and use thereof
CN103550248A (zh) 一种细菌纤维素/壳聚糖复合喷膜剂及其制备方法
CN100336564C (zh) 一种梯度结构壳聚糖水凝胶烧伤敷料及其制备方法